Tinea capitis: Two years experience in a paediatric hospital of Buenos Aires, Argentina.;Tinea capitis. Experiencia de 2 años en un hospital de pediatría de Buenos Aires, Argentina

Revista Iberoamericana de Micologia

Volumn 27, Issue 2, 2010, Pages 104-106

  Santos, Patricia Ester ^a   Córdoba, Susana ^b   Rodero, Laura L ^b   Carrillo Muñoz, Alfonso J ^c   Lopardo, Horacio A ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^c ACIAM   (Spain)

Author keywords

Antifungal agents; Celsus kerion; Dermatophytes; Tinea capitis

Indexed keywords

FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE; VORICONAZOLE;

ARGENTINA; ARTICLE; CHILD; FUNGUS ISOLATION; HUMAN; INCIDENCE; KERION; MICROSPORUM CANIS; MICROSPORUM CANIS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEDIATRIC HOSPITAL; TINEA CAPITIS; TREATMENT RESPONSE;

ANTIFUNGAL AGENTS; ARGENTINA; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MICROSPORUM; PROSPECTIVE STUDIES; TINEA CAPITIS; TRICHOPHYTON; URBAN POPULATION;

ARTHRODERMATACEAE; MICROSPORUM; MICROSPORUM CANIS; TRICHOPHYTON;

EID: 77952888094     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.riam.2010.01.004     Document Type: Article

References (25)

1. Araújo C.R., Miranda K.C., Fernandes Ode F., Soares A.J., Silva Mdo R. In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method. Rev Inst Med Trop Sao Paulo 2009, 51:9-12.
2. Carrillo-Muñoz A.J., Cárdenes C.D., Carrillo-Orive B., Rodríguez V., Del Valle O., Casals J.B., et al. In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis. Rev Iberoam Micol 2005, 22:110-113.
3. Carrillo-Muñoz A.J., Fernández-Torres B., Guarro J. In vitro antifungal activity of sertaconazole against 309 dermatophyte clinical isolates. J Chemother 2003, 15:555-557.
4. Carrillo-Muñoz A.J., Santos P., Del Valle O., Casals J.B., Quindós G. ¿Es activa la anfotericina B frente a hongos dermatofitos y Scopulariopsis brevicaulis?. Rev Esp Quimioter 2004, 17:244-249.
5. Cuétara M.S., Del Palacio A., Pereiro M., Amor E., Álvarez C., Noriega A.R. Prevalence of undetected tinea capitis in a school survey in Spain. Mycoses 1997, 40:131-137.
6. Cuétara M.S., Del Palacio A., Pereiro M., Noriega A.R. Prevalence of undetected tinea capitis in a prospective school survey in Madrid: Emergence of new causative fungi. Br J Dermatol 1998, 138:658-660.
7. Davel G., Perrotta D., Canteros C., Córdoba S., Rodero L., Brudny M., et al. Estudio multicéntrico de micosis superficiales en Argentina. Rev Argent Microbiol 1999, 31:173-181. Grupo EMMS.
8. Del Palacio A., Garau M., Cuétara M.S. Tratamiento actual de las dermatofitosis. Rev Iberoam Micol 2002, 19:69-71.
9. Develoux M. Griseofulvin. Ann Dermatol Venereol 2001, 128:1317-1325.
10. Fernández-Torres B., Cabañes F.J., Carrillo-Muñoz A.J., Esteban A., Inza I., Abarca L., et al. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002, 40:3999-4003.
11. Fernández-Torres B., Carrillo-Muñoz A., Inza I., Guarro J. Effect of culture medium on the disk diffusion method for determining antifungal susceptibilities of dermatophytes. Antimicrob Agents Chemother 2006, 50:2222-2224.
12. Fernández-Torres B., Inza I., Guarro J. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of dermatophytes with thick-wall macroconidia. Antimicrob Agents Chemother 2003, 47:3371-3372.
13. Fernández-Torres B., Inza I., Guarro J. Evaluation of disk diffusion method for determining eberconazole susceptibility of dermatophytes and influence of culture medium. Antimicrob Agents Chemother 2005, 49:2116-2118.
14. Fernández-Torres B., Pereiro M., Llovo J., Otero X.L., Toribio J. Influencia del tiempo de incubación en la determinación de la actividad antifúngica de la terbinafina frente a Trichophyton rubrum. Rev Iberoam Micol 1998, 15:290-293.
15. Fuller L.C. Changing face of tinea capitis in Europe. Curr Opin Infect Dis 2009, 22:115-118.
16. Guide NEO-SENSITABS Susceptibility testing, 20 ed. 2009. Rosco Diagnostica A/S.
17. Gupta A.K., Tu L.Q. Dermatophytes: Diagnosis and treatment. J Am Acad Dermatol 2006, 54:1050-1055.
18. Kwon-Chung K.J., Bennett J.E. Medical mycology, Malvern 1992, Pennsylvania, USA.
19. Mangiaterra M.L., Giusiano G.E., Alonso J.M., Pons de Storni L., Waisman R. Dermatofitosis en el gran área de Resistencia, Chaco, Argentina. Rev Argent Microbiol 1998, 30:79-83.
20. CLSI. Method for Antifungal Disk Diffusion Susceptibility Testing of Filamentous Fungi; Proposed Guideline. CLSI document M51-P. Wayne, PA. Clinical and Laboratory Standars Institute (2009) (ISBN Number 1-56238-702-2).
21. Clinical Laboratory and Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard. 2.nd Ed. CLSI document M38-A2 (ISBN 1-56238-668-9). Pennsylvania, EE. UU.: Wayne; 2008.
22. Niewerth M., Korting H.C. The use of systemic antimycotics in dermatotherapy. Eur J Dermatol 2000, 10:155-160.
23. Rippon J.W. Tratado de Micología Médica 1990, Interamericana Mc Graw-Hill, México, 186-225,244-292. 3 ed.
24. Santos D., Hamdam J.S. In vitro antifungal oral drug and drug -combination activity against onychomycosis causative dermatophytes. Med Mycol 2006, 44:357-362.
25. Torres Rodríguez J.M. Micosis que afectan piel y mucosas. Doyma 1987, 186:34-55.